RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.04368908262722241 | N/A |
Market Cap | $3.49M | N/A |
Shares Outstanding | 79.87M | N/A |
Employees | 9.00 | N/A |